Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11530410
Methods for treating hypercholesterolemia
granted -
US 11530411
Methods for reducing LRRK2 expression
granted -
US 11529337
Method of treating pain
granted -
US 11529340
Combination for treating pain
granted -
US 11530229
Cyano cyclobutyl compounds for CBL-B inhibition and uses thereof
granted -
US 11529312
Francisella lipids as broad anti-inflammatory therapeutics and associated methods of use
granted -
US 11530240
Catheter injectable cyclic peptide pro-gelators for myocardial tissue engineering
granted -
US 11529372
Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
granted -
US 11529375
Compositions and methods for treating diverticulitis and related disorders
granted -
US 11530248
T-cell modulatory multimeric polypeptides and methods of use thereof
granted -
US 11530393
Compositions comprising iduronate-2-sulfatase
granted -
US 11529314
Lipid-based nanoparticles for encapsulation and sustained release of therapeutic agents
granted -
US 11530220
Substituted imidazo[1,5-a]pyrazines and [1,2,4]triazolo[4,3-a]pyrazines for the modulation of AhR
granted -
US 11529381
Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
granted -
WO 2022258590
PROCÉDÉ D'ISOLEMENT DE PLASMINOGÈNE À PARTIR D'UNE FRACTION DE PLASMA SANGUIN
granted -
US 11525629
Target residual moisture content for lyophilized drug product
granted -
US 11525138
Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
granted -
US 11525136
Modulators of APOL1 expression
granted -
US 11524985
IL-37 fusion protein and methods of making and using same
granted -
US 11524955
2,4-diamino-pyrimidine compounds and method for making and using the compounds
granted -
US 11524948
Prodrugs of alpha-ketoglutarate, alpha-ketobutyrate, alpha-ketoisovalerate, and alpha-ketoisohexanoate, and uses thereof
granted -
US 11524051
Methods of treating fungal infections
granted -
US 11525001
Anti-CD8 antibodies and uses thereof
granted -
US 11524942
Metabolites of [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4 yl}-phenoxy)-propyl]-diethyl-amine
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.